Registration gives the benefit of site update e-mails and additional information from Takeda on new education materials and events.
ADHD Institute Register

Psychiatric comorbidities


eLearning module: Psychiatric comorbidities

 

Launch now

Missed the Neurobiology of ADHD disorder webinar?


Watch the Webinar now, participate in the knowledge checks and hear the Q&A panel discussion

Watch now

An interactive guide to the MOA of selected medications used in the treatment of ADHD


This is an MOA of pharmacological treatments only. Pharmacological treatment is not indicated for all patients and it must be used as part of a multimodal treatment approach

Launch now

Guidelines – UPDATE


Clinical guidelines are available to provide evidence-based recommendations for the management of ADHD to help guide appropriate and rational choices of treatment

Read more

ADHD is a lifelong disorder


ADHD is a chronic neurodevelopmental disorder which can affect children, adolescents and adults

Read more

The neurobiology of ADHD
is highly complex


Evidence exists for the association between ADHD and possible structural, functional and neurotransmitter alterations in various regions of the brain in children, adolescents and adults with ADHD

Read more

Assessment and diagnosis


ADHD assessment involves clinical examination, interviews and rating scales. Formal ADHD diagnosis typically utilises DSM-5TM or ICD-10 classification systems

Read more

Optimal management of ADHD


The optimal management of ADHD process should always consider input from the patient, family/caregivers and school to help establish an appropriate and extensive treatment programme (non-pharmacological and pharmacological therapy), goals and assessment/follow-up, resulting in a tailored multimodal treatment plan centred on the patient

Read more

Attention-deficit hyperactivity disorder (ADHD) is a diverse condition characterised by symptoms of inattention, hyperactivity and impulsivity; and can have a significant impact on patients’ lives.1,2 This website provides educational resources intended for healthcare professionals outside the US with an interest in ADHD. It aims to share scientific advances in ADHD research and provide expert opinions and medical education to support the healthcare professional community.

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 2013.
  2. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Available at: who.int/entity/classifications/icd/en/bluebook.pdf. Last updated 1993; 1: 1-263. Accessed February 2019.
Filter content by:

eLearning module: Psychiatric comorbidities

Missed the Adult ADHD and Neurology disorder webinar?

Participate in the knowledge checks and hear the Q&A panel discussion

Transition in ADHD

During transition from CAMHS to AMHS, adolescents may become lost in the system

Interactive module: ADHD across the lifespan

2017/2018 ADHD Guidelines

A summary of recommendations for pharmacological treatment from selected guidelines

An interactive guide to the MOA of selected medications used in the treatment of ADHD

Missed the Adult ADHD webinars?

On-demand webinars hosted by leading experts in the field. Participate in the knowledge checks and hear the Q&A panel discussion

ADHD Clinical Guidelines

View the videos from Meeting of Minds X, a scientific forum initiated, organised and funded by Shire, now part of Takeda

Interactive module: Understanding effect size

Transition in ADHD

Article written by Dr Kuben Naidoo, Clinical Director Sefton and Kirby, Mersey Care NHS Foundation Trust, UK

ADHD: improving visibility in adults

Overview of the impact of ADHD in adulthood and opportunities to improve recognition and management

UKAAN & EUNETHYDIS 2018

Reports from UK Adult ADHD Network meeting and 5th EUNETHYDIS International Conference on ADHD held in Scotland, UK

WCADHD 2017

6th World Congress on ADHD: From child to adult disorder. Vancouver, Canada, 20-22 April 2017

Meeting of Minds 2018 - clinical seminars

Held in Madrid, Spain: Advancing the science and clinical perspectives of ADHD across the life-course

Meeting of Minds 2018 -
Day 1 and 2

Held in Madrid, Spain: Advancing the science and clinical perspectives of ADHD across the life-course

Animation: Adult ADHD and the brain

Interactive module: Rating scale toolkit

An overview of rating scales used in the assessment of patients with ADHD

Animation: Childhood/Adolescent ADHD and treatment effects in the brain

Patient-centred management: every patient is different with unique needs – a Spanish perspective. Part 2: Treatment plans for children and adolescents

Adherence to treatment

Adherence to ADHD medication is often suboptimal, and can be encouraged by psychoeducation and the patient's acceptance of their condition

Assessment and Diagnosis

ADHD assessment involves clinical examination, interviews and rating scales

Impact of ADHD

ADHD can negatively impact the lives of patients and their families, affecting education, employment, finances and relationships

“Medication vacations” are positively associated with school outcomes in adolescents with ADHD

Barnard-Brak L et al. J Atten Disord 2018; Epub ahead of print

9 Mar 2018

Neurobiology

ADHD is associated with structural, functional and neurotransmitter alterations in the brain

Comorbidities

Psychiatric comorbidities are common in patients with ADHD, including bipolar disorder, major depression, substance abuse disorder, anxiety and phobias

Guidelines

Evidence-based or consensus-driven guidelines for the treatment of ADHD help consolidate practice internationally

Viewpoint: should the ADHD diagnostic criteria be revised?

Cortese S, Rohde LA. Lancet Child Adolesc Health 2019; 3: 844-845

27 Sep 2019

What do clinicians involved in transitioning adolescents with ADHD from child to adult services think about the recommendations from the NICE guidelines?

Eke H et al. Clin Care Health Dev 2020; 46: 111-120

20 Sep 2019

Clinical practice and opinions of adult ADHD in Germany

Schneider BC et al. J Atten Disord 2019; Epub ahead of print

13 Sep 2019

Prediction of current and retrospective symptoms of ADHD in adolescence and adulthood using virtual reality

Areces D et al. Brain Sci 2019; 9: E274.

6 Sep 2019

Practical considerations for adult ADHD: a French perspective

Weibel S et al. Encéphale 2019; Epub ahead of print

1 Sep 2019

How does a diagnosis of ADHD affect children with hyperactivity/inattention symptoms?

O’Connor C, McNicholas F. Child Psychiatry Hum Dev 2019; Epub ahead of print

30 Aug 2019

Developmental and environmental factors in adolescence may contribute to symptoms of late-onset ADHD

Sibley MH et al. Eur Child Adolesc Psychiatry 2019; Epub ahead of print

23 Aug 2019

The effect of long-term stimulant medication on growth trajectories in children with ADHD: results from the MTA study

Greenhill LL et al. J Am Acad Child Adolesc Psychiatry 2019; Epub ahead of print

16 Aug 2019


ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Takeda has no influence or control over the content of this third party website.

Continue Cancel